|Distribution of mitochondrial NADH fluorescence lifetimes: steady-state kinetics of matrix NADH interactions|
K Blinova, S Carroll, S Bose, AV Smirnov, JJ Harvey, JR Knutson, ...
Biochemistry 44 (7), 2585-2594, 2005
|Comprehensive translational assessment of human-induced pluripotent stem cell derived cardiomyocytes for evaluating drug-induced arrhythmias|
K Blinova, J Stohlman, J Vicente, D Chan, L Johannesen, ...
Toxicological Sciences 155 (1), 234-247, 2016
|Late sodium current block for drug‐induced long QT syndrome: results from a prospective clinical trial|
L Johannesen, J Vicente, JW Mason, C Erato, C Sanabria, K Waite‐Labott, ...
Clinical Pharmacology & Therapeutics 99 (2), 214-223, 2016
|Mitochondrial NADH fluorescence is enhanced by complex I binding|
K Blinova, RL Levine, ES Boja, GL Griffiths, ZD Shi, B Ruddy, RS Balaban
Biochemistry 47 (36), 9636-9645, 2008
|Use of 32P To Study Dynamics of the Mitochondrial Phosphoproteome|
AM Aponte, D Phillips, RK Hopper, DT Johnson, RA Harris, K Blinova, ...
Journal of proteome research 8 (6), 2679-2695, 2009
|International multisite study of human-induced pluripotent stem cell-derived cardiomyocytes for drug proarrhythmic potential assessment|
K Blinova, Q Dang, D Millard, G Smith, J Pierson, L Guo, M Brock, HR Lu, ...
Cell reports 24 (13), 3582-3592, 2018
|Common genetic variant risk score is associated with drug-induced QT prolongation and torsade de pointes risk: a pilot study|
DG Strauss, J Vicente, L Johannesen, K Blinova, JW Mason, P Weeke, ...
Circulation 135 (14), 1300-1310, 2017
|Use of human MonoMac6 cells for development of in vitro assay predictive of adjuvant safety in vivo|
M Zaitseva, T Romantseva, K Blinova, J Beren, L Sirota, D Drane, ...
Vaccine 30 (32), 4859-4865, 2012
|32P labeling of protein phosphorylation and metabolite association in the mitochondria matrix|
AM Aponte, D Phillips, RA Harris, K Blinova, S French, DT Johnson, ...
Methods in enzymology 457, 63-80, 2009
|Fluctuation analysis of mitochondrial NADH fluorescence signals in confocal and two‐photon microscopy images of living cardiac myocytes|
K Blinova, C Combs, P Kellman, RS Balaban
Journal of microscopy 213 (1), 70-75, 2004
|Differences in PGE2 production between primary human monocytes and differentiated macrophages: role of IL-1β and TRIF/IRF3|
Y Endo, K Blinova, T Romantseva, H Golding, M Zaitseva
PloS one 9 (5), e98517, 2014
|Clinical trials in a dish|
DG Strauss, K Blinova
Trends in pharmacological sciences 38 (1), 4-7, 2017
|Comprehensive in vitro proarrhythmia assay (CiPA) update from a cardiac safety research consortium/health and environmental sciences institute/FDA Meeting|
DG Strauss, G Gintant, Z Li, W Wu, K Blinova, J Vicente, JR Turner, ...
Therapeutic innovation & regulatory science 53 (4), 519-525, 2019
|Comparative analysis of media effects on human induced pluripotent stem cell-derived cardiomyocytes in proarrhythmia risk assessment|
D Schocken, J Stohlman, J Vicente, D Chan, D Patel, MK Matta, V Patel, ...
Journal of pharmacological and toxicological methods 90, 39-47, 2018
|Laser-induced saturation of fluorescence for complex organic molecules|
VI Yuzhakov, KG Yevsyukhina, SV Patsayeva
ALT'97 International Conference on Laser Surface Processing 3404, 388-396, 1998
|Acute effects of nonexcitatory electrical stimulation during systole in isolated cardiac myocytes and perfused heart|
K Blinova, J Stohlman, V Krauthamer, A Knapton, E Bloomquist, RA Gray
Physiological reports 2 (8), e12106, 2014
|Assessment of proarrhythmic potential of drugs in optogenetically paced induced pluripotent stem cell-derived cardiomyocytes|
D Patel, J Stohlman, Q Dang, DG Strauss, K Blinova
Toxicological Sciences 170 (1), 167-179, 2019
|Steady state kinetic properties of NADH binding and utilization in the mitochondrial matrix. A NADH fluorescence lifetime study.|
K Blinova, S Carroll, SK Bose, AV Smirnov, JJ Harvey, JR Knutson, ...
Biophysical Journal 86 (1), 469A-469A, 2004
|Clinical Trial in a Dish: Personalized Stem Cell–Derived Cardiomyocyte Assay Compared With Clinical Trial Results for Two QT‐Prolonging Drugs|
K Blinova, D Schocken, D Patel, C Daluwatte, J Vicente, JC Wu, ...
Clinical and translational science, 2019
|Evaluating the use of microelectrode array technology and cell-based neuronal culture models for proconvulsant risk assessment: progress from the HESI NeuTox consortium|
DC Millard, AM Nicolini, CA Arrowood, HB Hayes, JA Bradley, CJ Strock, ...
Journal of Pharmacological and Toxicological Methods 99, 106595, 2018